Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Asahi Kasei Corporation

Korea’s Clinical Trial Approvals Up 10%, But Still Below Pandemic Peak

South Korea’s clinical trial approvals rebounded in 2023, but remained lower than the peak levels in 2020-21 amid then robust R&D activity related to COVID-19. Last year's tally showed a mix of single-country and multinational trials and reflected the ongoing dominance of oncology in industry pipelines.

South Korea Clinical Trials

Korea Q1 Roundup: Pharma Begins To Feel Impact From Doctors’ Walkout

As South Korea's doctors continue their long-running protest against a government plan to raise the medical student quota at universities, the walk-outs may be beginning to take a toll on the pharma industry, with many large firms reporting weak earnings in the last quarter.

South Korea Sales & Earnings

GlycoMimetics Forges Ahead With Uproleselan In AML After Phase III Failure

The company said an NCI trial and a China study remain ongoing despite a Phase III study in relapsed/refractory disease failing, with an unusually long OS result in the control arm.

Clinical Trials Business Strategies

Avistone Wins China Approval For First C-Met Inhibitor In Glioblastoma

A China green light for domestic firm Avistone's c-Met inhibitor was based on positive outcomes from the Phase II/III FUGEN study in Chinese patients with recurrent relapsing glioma with the rare PTPRZ1-MET fusion gene. Avistone’s overseas partner Apollomics is also studying the molecule in a Phase II program outside China.

China Approvals
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Advanced Circulatory Systems, Inc.
    • Artisan Pharmaceuticals
    • Asahi Kasei Holdings US, Inc.
    • Asahi Kasei Pharma America Corp. (AKP America)
    • Cardiac Science Corporation
    • Golden Hour Data Systems, Inc.
    • Kyma Medical Technologies, Ltd.
    • Mobilize RRS LLC.
    • TherOx, Inc.
    • Veloxis Pharmaceuticals Inc.
    • ZOLL Medical Corporation
UsernamePublicRestriction

Register